Tag: Pharmaceutical Industry
Trump’s Approach to Drug Pricing Plan: What to Expect
President Trump is like totally gonna try to push this “most-favored nation” policy next week to like bring down drug prices in the U.S....
ATTR-CM Drug Race: Alnylam’s Entry
Alnylam's Amvuttra: A Game-Changer in the ATTR-CM Drug RaceAlnylam Pharmaceuticals has made waves in the pharmaceutical industry with the FDA's recent approval of their...
Suspend U.S. patents on medicines to fight U.S. tariffs
In the wake of the recent imposition of 25% tariffs on goods from Canada by the Trump administration, the Canadian government is responding with...
Generic Drugmakers Prevail in California Pay-to-Delay Ban Battle
In a recent turn of events, a federal judge has ruled in favor of generic drugmakers in California's battle against pay-to-delay agreements. This controversial...
Threat to Pharmaceutical Public-Private Partnerships: Gilead’s Short-Term Win
In December 2024, a group of legal, medical, and public health experts united to file an amicus brief in support of the U.S. government...
CRISPR Crisis, RFK Jr. Promises, Non-Opioid Pain Drug Solution
In the fast-paced world of biotechnology, the landscape is constantly shifting, with new developments and challenges emerging every day. The recent turmoil in the...
Kura Oncology Licenses Leukemia Drug to Japanese Drugmaker
Kura Oncology and the Japanese drugmaker Kyowa Kirin have joined forces in a global partnership to work on Kura’s new treatment for acute leukemia....
Assessing the Cost-Effectiveness of Alzheimer’s Drug Donanemab in the U.K.
The recent decision by the U.K.'s National Institute for Health and Care Excellence (NICE) regarding the cost-effectiveness of the Alzheimer's drug Donanemab, also known...
Expanding Access to HIV Prevention Drug: ViiV Faces Criticism
ViiV Healthcare recently announced plans to increase access to its HIV prevention medication in low- and middle-income countries. This marks the second time in...
Pfizer CEO’s Vision for Leading Cancer and Obesity Treatments
Albert Bourla, the CEO of Pfizer, is looking to shift the focus of the company from its successful COVID-19 vaccine and antiviral Paxlovid to...
FDA Requests Further Research before Approving MDMA Therapy
The Food and Drug Administration (FDA) recently declined to approve MDMA-assisted therapy for the treatment of post-traumatic stress disorder (PTSD), citing insufficient data to...
New FDA-Approved Overdose-Reversal Medication by Purdue Pharma
Purdue Pharma, infamous for its role in the opioid crisis, has received FDA approval for a new auto-injector device designed to reverse opioid overdoses....
BREAKING NEWS
Biden’s Prostate Cancer Diagnosis: What You Need to Know
Former President Joe Biden has been hit with some tough news as his office announced on Sunday that he has been diagnosed with prostate...
